Cardiovascular imaging can serve as a primary endpoint for monitoring drug and medical device efficacy as well as assessing the cardiac safety of new therapies. As the world's largest imaging core lab, BioClinica has the expertise you want and the imaging solutions you need to successfully support your cardiovascular clinical trial. Our medical affairs, technologists and operational teams have the experience and skills to deliver high quality service, image analysis and expert independent image review in support of your cardiovascular trial.
BioClinica's cardiovascular expertise is reflected in the form of support for the latest developments in imaging endpoints including qualitative and quantitative image analysis for all imaging modalities. Our staff ensures full 21 CFR Part 11 compliance and maintains contact with the FDA to implement regulatory guidance.
When you choose BioClinica, you can be sure you are getting the best in the following areas:
Work with a dedicated cardiovascular team.
On staff cardiologists and a network of industry leaders.
Expertise navigating through regulatory guidance.
28 years of experience with cardiovascular studies.
Quantitative cardiovascular modalities and endpoints.
Strong operational foundation ensures timely results.